NovaPoint Capital’s Genelux GNLX Stock Holding History

NovaPoint Capital’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,856	Closed	-$82.7K	–	136
2024 Q1	$82.7K	Buy	+12,856	New	+$117K	0.03%	136

Other funds holding GNLX

WDC

Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

NovaPoint Capital's GNLX Position: Q2 2024 in Review

NovaPoint Capital sold out of Genelux (GNLX) in Q2 2024, closing a stake of 12,856 shares — an estimated $82.7K sold.

NovaPoint Capital first reported a position in GNLX in Q1 2024 and held it in 1 quarter. The position peaked at $82.7K in Q1 2024. 73 funds tracked by Wall St. Rank hold GNLX as of Q2 2024.

NovaPoint Capital reported no remaining Genelux position as of Q2 2024 after selling out during the quarter.
NovaPoint Capital sold 12,856 Genelux shares in Q2 2024, an estimated $82.7K.
NovaPoint Capital first reported a position in Genelux in Q1 2024 and held it in 1 quarter.
NovaPoint Capital's Genelux position peaked at $82.7K in Q1 2024.
73 funds tracked by Wall St. Rank held Genelux as of Q2 2024.

Based on NovaPoint Capital's 13F filing for Q2 2024, filed 10 Jul 2024.